TLOG Stock - TetraLogic Pharmaceuticals Corporation
Unlock GoAI Insights for TLOG
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | $-187,993 | N/A | N/A | N/A | N/A |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-44,991,026 | $-33,785,603 | $-17,990,894 | $-16,171,927 | $-18,869,349 |
| Net Income | $-56,108,339 | $-39,318,368 | $-22,717,818 | $-16,272,803 | $-18,926,409 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-2.37 | $-1.76 | $-9.90 | $-16.78 | $-14.80 |
TetraLogic Pharmaceuticals Corporation, a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule therapeutics in oncology and infectious diseases. It has two clinical-stage product candidates in development, such as birinapant and SHAPE. Birinapant is a small molecule therapeutic that mimics Second Mitochondrial Activator of Caspases-mimetic, which leads to apoptosis or cell-death in damaged cells. SHAPE is its proprietary histone deacetylase inhibitor for topical use for the treatment of early-stage cutaneous T-cell lymphoma. TetraLogic Pharmaceuticals Corporation has research collaboration with Walter and Eliza Hall Institute of Medical Research to examine SMAC-mimetics, including birinapant in the treatment of infectious disease. The company was formerly known as Gentara Corporation and changed its name to TetraLogic Pharmaceuticals Corporation in January 2006. TetraLogic Pharmaceuticals Corporation was incorporated in 2001 and is headquartered in Malvern, Pennsylvania.
Visit WebsiteEarnings History & Surprises
TLOGEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q4 2016 | Nov 3, 2016 | — | $-0.08 | — | — |
Q3 2016 | Aug 11, 2016 | — | $-0.22 | — | — |
Q2 2016 | May 4, 2016 | — | $-0.45 | — | — |
Q1 2016 | Mar 16, 2016 | — | $-0.76 | — | — |
Q4 2015 | Nov 4, 2015 | — | $-0.34 | — | — |
Q3 2015 | Aug 5, 2015 | — | $-0.32 | — | — |
Q2 2015 | May 14, 2015 | — | $-0.25 | — | — |
Q1 2015 | Feb 26, 2015 | — | $-0.38 | — | — |
Q4 2014 | Nov 5, 2014 | $-0.34 | $-0.42 | -23.5% | ✗ MISS |
Q3 2014 | Aug 5, 2014 | $-0.29 | $-0.42 | -44.8% | ✗ MISS |
Q2 2014 | May 8, 2014 | $-0.30 | $-0.25 | +16.7% | ✓ BEAT |
Q4 2013 | Dec 31, 2013 | — | $-0.30 | — | — |
Q3 2013 | Sep 30, 2013 | — | $-3.79 | — | — |
Q2 2013 | Jun 30, 2013 | — | $-3.37 | — | — |
Q1 2013 | Mar 31, 2013 | — | $-3.12 | — | — |
Q4 2012 | Dec 31, 2012 | — | $-2.41 | — | — |
Q3 2012 | Sep 30, 2012 | — | $-2.32 | — | — |
Latest News
Frequently Asked Questions about TLOG
What is TLOG's current stock price?
What is the analyst price target for TLOG?
What sector is TetraLogic Pharmaceuticals Corporation in?
What is TLOG's market cap?
Does TLOG pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to TLOG for comparison